Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

被引:28
|
作者
Alaaeldin, Rania [1 ]
Ali, Fares E. M. [2 ]
Bekhit, Amany Abdlrehim [3 ]
Zhao, Qing-Li [4 ]
Fathy, Moustafa [3 ,5 ]
机构
[1] Deraya Univ, Fac Pharm, Dept Biochem, Al Minya 61111, Egypt
[2] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Assiut Branch, Assiut 71524, Egypt
[3] Minia Univ, Fac Pharm, Dept Biochem, Al Minya 61519, Egypt
[4] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 9300194, Japan
[5] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300194, Japan
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
azilsartan; breast cancer; NF-kB; EMT; IL-6; JAK2; STAT3; SLUG; TWIST; SNAIL; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; APOPTOSIS; RECEPTOR; EMT; COMBINATIONS; INFLAMMATION; MODULATION; MIGRATION; SLUG;
D O I
10.3390/molecules27227825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastatic breast cancer is an incurable form of breast cancer that exhibits high levels of epithelial-mesenchymal transition (EMT) markers. Angiotensin II has been linked to various signaling pathways involved in tumor cell growth and metastasis. The aim of this study is to investigate, for the first time, the anti-proliferative activity of azilsartan, an angiotensin II receptor blocker, against breast cancer cell lines MCF-7 and MDA-MB-231 at the molecular level. Cell viability, cell cycle, apoptosis, colony formation, and cell migration assays were performed. RT-PCR and western blotting analysis were used to explain the molecular mechanism. Azilsartan significantly decreased the cancer cells survival, induced apoptosis and cell cycle arrest, and inhibited colony formation and cell migration abilities. Furthermore, azilsartan reduced the mRNA levels of NF-kB, TWIST, SNAIL, SLUG and bcl2, and increased the mRNA level of bax. Additionally, azilsartan inhibited the expression of IL-6, JAK2, STAT3, MMP9 and bcl2 proteins, and increased the expression of bax, c-PARP and cleaved caspase 3 protein. Interestingly, it reduced the in vivo metastatic capacity of MDA-MBA-231 breast cancer cells. In conclusion, the present study revealed, for the first time, the anti-proliferative, apoptotic, anti-migration and EMT inhibition activities of azilsartan against breast cancer cells through modulating NF-kB/IL-6/JAK2/STAT3/MMP9, TWIST/SNAIL/SLUG and apoptosis signaling pathways.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway
    Jiao, X. X.
    Lin, S. Y.
    Lian, S. X.
    Qiu, Y. R.
    Li, Z. H.
    Chen, Z. H.
    Lu, W. Q.
    Zhang, Y.
    Deng, L.
    Jiang, Y.
    Hu, G. H.
    NEOPLASMA, 2020, 67 (04) : 834 - 842
  • [22] Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients
    Zhuang, Mengqi
    Ding, Xiaotong
    Song, Wenli
    Chen, Huimin
    Guan, Hui
    Yu, Yang
    Zhang, Zicheng
    Dong, Xinzhe
    AGING-US, 2021, 13 (12): : 16667 - 16683
  • [23] Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas
    Colomiere, M.
    Ward, A. C.
    Riley, C.
    Trenerry, M. K.
    Cameron-Smith, D.
    Findlay, J.
    Ackland, L.
    Ahmed, N.
    BRITISH JOURNAL OF CANCER, 2009, 100 (01) : 134 - 144
  • [25] Resolvin D1 Inhibits IL-6-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Targeting IL-6/STAT3 Signaling
    Du, Heng
    You, Lijuan
    Wu, Anding
    Wang, Fei
    Yu, Jie
    Chen, Chaowu
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (02) : 1453 - 1461
  • [26] Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/STAT3 and TGF-β/SMAD3 signaling pathway
    Wang, Wu-ping
    Sun, Ying
    Lu, Qiang
    Zhao, Jin-bo
    Wang, Xue-jiao
    Chen, Zhao
    Ni, Yun-feng
    Wang, Ju-zheng
    Han, Yong
    Zhang, Zhi-pei
    Yan, Xiao-long
    Li, Xiao-fei
    ONCOTARGET, 2017, 8 (04) : 5909 - 5923
  • [27] JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
    Liu, Reng-Yun
    Zeng, Yuanyuan
    Lei, Zhe
    Wang, Longqiang
    Yang, Haiping
    Liu, Zeyi
    Zhao, Jun
    Zhang, Hong-Tao
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (05) : 1643 - 1651
  • [28] Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer
    Wan, Min
    Yu, Hong
    Zhai, Haoqing
    MOLECULAR BIOTECHNOLOGY, 2024, 67 (4) : 1526 - 1538
  • [29] NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer
    Liu, Suqing
    Sun, Jing
    Cai, Bin
    Xi, Xiaowei
    Yang, Liu
    Zhang, Zhenbo
    Feng, Youji
    Sun, Yunyan
    TUMOR BIOLOGY, 2016, 37 (07) : 9671 - 9680
  • [30] Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma
    Yang, Min
    Yao, Panpan
    Lang, Xuqiang
    Li, Xue
    Zhang, Dawei
    BIOENGINEERED, 2021, 12 (02) : 12800 - 12811